Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002020 · ClinicalTrials.gov registry record · NA
Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC
A NA study of HIV Infections, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
- 12
- Study locations
NCT00002020 is a NA study of HIV Infections that has completed, run by Glaxo Wellcome. The trial reports 12 study locations across 9 states.
The verdict
NCT00002020, a NA study of HIV Infections, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
- 12
- Study locations
Study Summary
To evaluate the safety and tolerance, in patients with severe clinical manifestations of HIV infection, of zidovudine (AZT) administered daily for 48 weeks as a low dose every 4 hours or a higher dose every 12 hours.
Conditions Studied
Interventions
- DRUG Zidovudine
Study Locations (12)
Illinois
- Northwestern Univ Med School - Chicago
- Cook County Hosp - Chicago
- Rush Presbyterian - Saint Luke's Med Ctr - Chicago
Texas
- Univ TX Galveston Med Branch - Galveston
- Baylor College of Medicine - Houston
Arizona
- Univ of Arizona / Health Science Ctr - Tucson
Missouri
- Univ of Missouri at Kansas City School of Medicine - Kansas City
New Jersey
- North Jersey Community Research Initiative - Newark
New Mexico
- Univ of New Mexico Hlth Sciences Ctr / Dept of Med - Albuquerque
New York
- Northshore Hosp / Cornell Univ - Manhasset
Pennsylvania
- Univ of Pennsylvania / HIV Clinic - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002020
The ClinicalTrials.gov registry entry for NCT00002020 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Glaxo Wellcome, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Zidovudine is the first listed.
NCT00002020 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Texas, Arizona.
Frequently Asked Questions
What is clinical trial NCT00002020 about?
NCT00002020 is a clinical study titled "Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC". To evaluate the safety and tolerance, in patients with severe clinical manifestations of HIV infection, of zidovudine (AZT) administered daily for 48 weeks as a low dose every 4 hours or a higher dose every 12 hours.
What is the current status of trial NCT00002020?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002020 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00002020?
The interventions under investigation include: Zidovudine (DRUG).
Who is sponsoring clinical trial NCT00002020?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002020 being conducted?
This trial has 12 study locations across Arizona, Illinois, Missouri, New Jersey, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.